ASCO announces 2022-2023 president
Click Here to Manage Email Alerts
Eric P. Winer, MD, FASCO, has been elected ASCO president for the 2022-2023 term.
Winer will become president-elect during ASCO Annual Meeting in 2021, and he will assume the presidency in June 2022.
“I am deeply honored to be named president-elect of ASCO and serve our members who are committed to improving patient care around the world,” Winer said in a press release. “ASCO is as equally devoted to improving outcomes for patients as it is to supporting oncology professionals and enhancing their ability to deliver the best possible care, and I look forward to supporting the ASCO mission in this role.”
Winer is chief clinical development officer, senior vice president for medical affairs, chief of the division of breast oncology and Thompson chair in breast cancer research at Dana-Farber Cancer Institute. He also is professor of medicine at Harvard Medical School.
Winer served on ASCO’s board of directors from 2011 to 2015. He previously served as chair of the society’s government relations committee, cancer communications committee and health services research committee.
ASCO also announced the election of three members to ASCO’s board of directors and two members to its nominating committee.
The newly elected board members are Gladys I. Rodriguez, MD, vice president of clinical research at South Texas Oncology and Hematology at the START Center for Cancer Care and co-manager of South Texas Accelerated Research Therapeutics; Taofeek K. Owonikoko, MD, PhD, director of thoracic oncology, co-leader of the discovery and developmental therapeutics research program, and chair of the aerodigestive malignancies working group at Winship Cancer Institute, and a professor and vice chair for faculty development in the department of hematology and medical oncology at Emory University; and Mariana Chavez Mac Gregor, MD, MSc, associate professor in the department of health services research and associate professor in the department of breast medical oncology at The University of Texas MD Anderson Cancer Center.
Rodriguez, Owonikoko and Chavez Mac Gregor will begin their 4-year terms in June.
The newly elected members of the ASCO nominating committee are Merry Jennifer Markham, MD, FACP, FASCO, interim chief of the division of hematology and oncology and professor at University of Florida and associate director for medical affairs at UF Health Cancer Center, and Nathan A. Pennell, MD, PhD, FASCO, director of the lung cancer medical oncology program at Cleveland Clinic Foundation and professor of medicine at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Markham and Pennell will serve 3-year terms on the committee.
Read more about
Click Here to Manage Email Alerts